In an interim order issued yesterday, the regulator has restrained Unickon Securities and its directors Gajendra Nagpal and Ram Mohan Gupta from accessing the securities "either directly or indirectly or being associated with the securities market in any manner whatsoever, with immediate effect, till further direction."
The Securities and Exchange Board of India (Sebi) has received a large number of complaints from the clients of Unickon Securities for non-receipt/delay in payment of funds and accordingly advised the company to resolve complaints expeditiously.
It also advised NSE (National Stock Exchange), BSE and securities depository CDSL (Central Depository Services (India) Ltd (CDSL) to conduct inspection of Unickon Securities.
Sebi found that Unickon Securities have violated various norms including non-redressal of investor grievances pertaining to "non-receipt of funds/securities by clients"
Also Read
"Unickon did not furnish the complete material information to Sebi as was sought by it during the inspection and the limited information furnished to Sebi in respect of its bank accounts and the status of unresolved complaints against it pending," Sebi noted.
"...The conduct of Unickon Securities and its promoters/directors is not in the interest of investors in the securities market," it added.
In a separate order, Sebi has disposed off a case against Trinity Bio-Tech Ltd in a matter related to the alleged failure of the company to redress investors' complaint.
Sebi observed that one investor complaint was pending against the company.
"It has been confirmed that the company has obtained SCORES authentication on May 16, 2013, and has also resolved the investor complaint referred in the SCN," the regulator said in an order dated May 26.